Researchers are conducting a phase 1 trial of multiple maintenance regimens in patients with extensive-stage small-cell lung cancer.
All articles by Cancer Therapy Advisor Staff
Researchers are conducting a phase 2 trial of the WEE1 inhibitor AZD1775 in combination with carboplatin and paclitaxel for patients with advanced/metastatic squamous cell lung cancer.
Patients in the first arm will undergo single booster vaccination, and patients in the second arm will undergo full revaccination.
Latest News Your top articles for SaturdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses